Olanzapine LAI (mdc-TJK / TEV-‘749) is an investigational, once-monthly, subcutaneous long-acting injection of the atypical antipsychotic olanzapine for the treatment of schizophrenia. This is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback